-
CORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in India
-
Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India
-
Monogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder Community
-
Monogram Technologies (MGRM) Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System
-
Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System
-
CORRECTION: Monogram Technologies Reports Full Year 2024 Financial Results
-
Monogram Technologies Reports Full Year 2024 Financial Results
-
Monogram Technologies to Participate in the 37th Annual ROTH Conference in California March 16-18, 2025
-
Monogram Technologies to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday, March 12, 2025 at 4:30 p.m. Eastern Time
-
Monogram Technologies (MGRM) Provides Regulatory Update on mBôs TKA System
-
Monogram Technologies Provides Regulatory Update on mBôs TKA System and Clinical Trial Preparation in India
-
Monogram Technologies (MGRM) Provides 510(k) Submission Update Following Positive Meeting with FDA
-
Monogram Technologies Provides 510(k) Submission Update Following Positive Meeting with FDA
-
Roth/MKM Starts Monogram Technologies Inc (MGRM) at Buy
-
Monogram Technologies Announces Management and Related Parties Complete Open Market Purchases of MGRM Common Stock Totaling $1 Million
-
Monogram Technologies Reports Third Quarter 2024 Financial Results
-
Monogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern Time
-
Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
-
Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
-
CORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System
-
Monogram Technologies (MGRM) Receives FDA Response for mBos TKA System
-
Monogram Technologies Receives FDA Response for mBôs TKA System
-
Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
-
Monogram Technologies Announces Preferred Stock Dividends
-
Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million
-
Monogram Technologies Inc. (MGRM) Reports In-Line Q2 EPS
-
Monogram Technologies Reports Second Quarter 2024 Financial Results
-
Monogram Technologies (MGRM) Secures Initial Strategic Clinical Trial Collaboration
-
Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration
-
Monogram Orthopaedics (MGRM) Submits 510(k) Application for mBos TKA System Clearance
-
Monogram Technologies Submits 510(k) Application for mBôs TKA System Clearance
-
Monogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
-
Monogram Orthopaedics (MGRM) Launches $10M Preferred Units Offering
-
Monogram Technologies Launches Continuous Offering of 8.00% Convertible Preferred Stock and Warrants

